Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 10, 2012 - Issue 5
Submit an article Journal homepage
243
Views
28
CrossRef citations to date
0
Altmetric
Special Report

Standby emergency treatment of malaria in travelers: experience to date and new developments

Patricia Schlagenhauf University of Zürich Centre for Travel Medicine, Institute for Social and Preventive Medicine, University of Zürich, Zürich, Switzerland. [email protected]; University of Zürich Centre for Travel Medicine, Institute for Social and Preventive Medicine, University of Zürich, Zürich, Switzerland. [email protected]
&
Eskild Petersen Department of Infectious Diseases, Aarhus University Hospital, Skejby, Aarhus, Denmark; Department of Infectious Diseases, Aarhus University Hospital, Skejby, Aarhus, Denmark
Pages 537-546 | Published online: 10 Jan 2014

References

  • Schlagenhauf P, Petersen E. Malaria chemoprophylaxis: strategies for risk groups. Clin. Microbiol. Rev. 21(3), 466–472 (2008).
  • Jelinek T, Schulte C, Behrens R et al. Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin. Infect. Dis. 34(5), 572–576 (2002).
  • Weber R, Schlagenhauf P, Amsler L, Steffen R. Knowledge, attitudes and practices of business travelers regarding malaria risk and prevention. J. Travel Med. 10(4), 219–224 (2003).
  • Phillips-Howard PA, Bradley DJ, Blaze M, Hurn M. Malaria in Britain: 1977–86. Br. Med. J. (Clin. Res. Ed.) 296(6617), 245–248 (1988).
  • Christen D, Steffen R, Schlagenhauf P. Deaths caused by malaria in Switzerland 1988-2002. Am. J. Trop. Med. Hyg. 75(6), 1188–1194 (2006).
  • Jelinek T, Schade Larsen C, Siikamäki H et al. European cluster of falciparum malaria from Gambia. Euro. Surveill. 13(51), pii (2008).
  • Mali S, Kachur SP, Arguin PM; Division of Parasitic Diseases and Malaria, Center for Global Health. Malaria surveillance - USA, 2010. MMWR. Surveill. Summ. 61(2), 1–17 (2012).
  • Legros F, Bouchaud O, Ancelle T et al.; for the French National Reference Centers for Imported and Autochthonous Malaria Epidemiology and Chemosensitivity Network. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996–2003. Emerging Infect. Dis. 13(6), 883–888 (2007).
  • Seringe E, Thellier M, Fontanet A et al.; French National Reference Center for Imported Malaria Study Group. Severe imported Plasmodium falciparum malaria, France, 1996–2003. Emerging Infect. Dis. 17(5), 807–813 (2011).
  • Kain KC, MacPherson DW, Kelton T, Keystone JS, Mendelson J, MacLean JD. Malaria deaths in visitors to Canada and in Canadian travellers: a case series. CMAJ 164(5), 654–659 (2001).
  • Newman RD, Parise ME, Barber AM, Steketee RW. Malaria-related deaths among U.S. travelers, 1963–2001. Ann. Intern. Med. 141(7), 547–555 (2004).
  • Mühlberger N, Jelinek T, Behrens RH et al. TropNetEuropSurveillance importierter Infektionen in Deutschland Surveillance Networks. Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin. Infect. Dis. 36(8), 990–995 (2003).
  • Krause G, Schöneberg I, Altmann D, Stark K. Chemoprophylaxis and malaria death rates. Emerging Infect. Dis. 12(3), 447–451 (2006).
  • Chen LH, Wilson ME, Schlagenhauf P. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA 297(20), 2251–2263 (2007).
  • Schlagenhauf P, Tschopp A, Johnson R et al. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. BMJ 327(7423), 1078 (2003).
  • Steffen R, Fuchs E, Schildknecht J et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 341(8856), 1299–1303 (1993).
  • Askling HH, Nilsson J, Tegnell A, Janzon R, Ekdahl K. Malaria risk in travelers. Emerging Infect. Dis. 11(3), 436–441 (2005).
  • Schmid S, Chiodini P, Legros F et al. The risk of malaria in travelers to India. J. Travel Med. 16(3), 194–199 (2009).
  • Behrens RH, Carroll B, Hellgren U et al. The incidence of malaria in travellers to south-east Asia: is local malaria transmission a useful risk indicator? Malar. J. 9, 266 (2010).
  • Schlagenhauf P. Stand-by emergency treatment of malaria by travellers. In: Travelers’ Malaria (2nd Edition). Schlagenhauf-Lawlor P (Ed.). BC Decker, ON, Canada, 316–322 (2008).
  • Schlagenhauf P, Steffen R, Tschopp A et al. Behavioural aspects of travellers in their use of malaria presumptive treatment. Bull. World Health Organ. 73(2), 215–221 (1995).
  • Bhattarai A, Ali AS, Kachur SP et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 4(11), e309 (2007).
  • Poravuth Y, Socheat D, Rueangweerayut R et al. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. PLoS ONE 6(1), e14501 (2011).
  • Phyo AP, Lwin KM, Price RN et al. Dihydroartemisinin–piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial. Clin. Infect. Dis. 53(10), 977–984 (2011).
  • Weinke T, Trautmann M, Held T et al. Neuropsychiatric side effects after the use of mefloquine. Am. J. Trop. Med. Hyg. 45(1), 86–91 (1991).
  • Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. Am. J. Trop. Med. Hyg. 55(Suppl. 1), 50–56 (1996).
  • Schlagenhauf P, Blumentals W, Suter P et al. Pregnancy and fetal outcomes after exposure to mefloquine in the perinatal and pregnancy periods. Clin. Infect. Dis. doi:10.1093/cid/cis215 (2012) (Epub ahead of print).
  • McGready R, Lee S, Wiladphaingern J et al. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect. Dis. 12(5), 388–396 (2011).
  • Morris CA, Onyamboko MA, Capparelli E et al. Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria. Malar. J. 10, 114 (2011).
  • Gargano N, Cenci F, Bassat Q. Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties. Trop. Med. Int. Health doi:10.1111/j.1365-3156.2011.02855.x (2011) (Epub ahead of print).
  • Yavo W, Faye B, Kuete T et al. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin–piperaquine compared to artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Malar. J. 10, 198 (2011).
  • Mayxay M, Keomany S, Khanthavong M et al. A Phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin–piperaquine in comparison with artesunate–mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos. Am. J. Trop. Med. Hyg. 83(6), 1221–1229 (2010).
  • Nothdurft HD, Jelinek T, Pechel SM et al. Stand-by treatment of suspected malaria in travellers. Trop. Med. Parasitol. 46(3), 161–163 (1995).
  • Newton PN, Green MD, Fernández FM, Day NP, White NJ. Counterfeit anti-infective drugs. Lancet Infect. Dis. 6(9), 602–613 (2006).
  • Newton PN, Green MD, Fernandez F. Counterfeit artemisinin derivatives and Africa: update from authors. PLoS Med. 4(3), e139 (2007).
  • Newton PN. Chapter 20. In: Travelers’ Malaria (2nd Edition). Schlagenhauf-Lawlor P (Ed.). BC Decker, ON, Canada, 331–342 (2008).
  • Uguen C, Rabodonirina M, De Pina JJ et al. ParaSight-F rapid manual diagnostic test of Plasmodium falciparum infection. Bull. World Health Organ. 73(5), 643–649 (1995).
  • Funk M, Schlagenhauf P, Tschopp A, Steffen R. MalaQuick versus ParaSight F as a diagnostic aid in travellers’ malaria. Trans. R. Soc. Trop. Med. Hyg. 93(3), 268–272 (1999).
  • Petersen E, Marbiah NT, New L, Gottschau A. Comparison of two methods for enumerating malaria parasites in thick blood films. Am. J. Trop. Med. Hyg. 55(5), 485–489 (1996).
  • Gama BE, Silva-Pires Fdo E, Lopes MN et al. Real-time PCR versus conventional PCR for malaria parasite detection in low-grade parasitemia. Exp. Parasitol. 116(4), 427–432 (2007).
  • Grobusch MP, Hänscheid T, Göbels K et al. Sensitivity of P. vivax rapid antigen detection tests and possible implications for self-diagnostic use. Travel Med. Infect. Dis. 1(2), 119–122 (2003).
  • Jelinek T. Malaria self-testing by travellers: opportunities and limitations. Travel Med. Infect. Dis. 2(3–4), 143–148 (2004).
  • Berg J, Breederveld D, Roukens AH et al. Knowledge, attitudes, and practices toward malaria risk and prevention among frequent business travelers of a major oil and gas company. J. Travel Med. 18(6), 395–401 (2011).
  • Luchavez J, Baker J, Alcantara S et al. Laboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management. Malar. J. 10, 286 (2011).
  • Gillet P, Scheirlinck A, Stokx J et al. Prozone in malaria rapid diagnostics tests: how many cases are missed? Malar. J. 10, 166 (2011).
  • Koita OA, Doumbo OK, Ouattara A et al. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am. J. Trop. Med. Hyg. 86(2), 194–198 (2012).
  • Baker J, Gatton ML, Peters J, Ho MF, McCarthy JS, Cheng Q. Transcription and expression of Plasmodium falciparum histidine-rich proteins in different stages and strains: implications for rapid diagnostic tests. PLoS One 6(7), e22593 (2011).
  • Chiodini PL, Bowers K, Jorgensen P et al. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans. R. Soc. Trop. Med. Hyg. 101(4), 331–337 (2007).
  • Sutherland CJ, Tanomsing N, Nolder D et al. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J. Infect. Dis. 201(10), 1544–1550 (2010).
  • Tordrup D, Virenfeldt J, Andersen FF, Petersen E. Variant Plasmodium ovale isolated from a patient infected in Ghana. Malar. J. 10(1), 15 (2011).
  • Hellemond JJ, van Rutten M, Koelewijn R et al. Human Plasmodium knowlesi infection detected by rapid diagnostic tests for malaria. Emerg. Infect. Dis. 15, 1478–1480 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.